Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 47-52

  Triozzi, P L ^a,b   Tucker, F ^a   Benzies, T ^a   Balcerzak, S P ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Interferon ; Interleukin 2; Lymphokine activated killer; Macrophage cytotoxicity; Natural killer cell

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TETANUS TOXOID;

ACCESSORY CELL; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVITY; CELL MEDIATED CYTOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; LEUKAPHERESIS; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOTOXICITY; LYMPHOID CELL; MALE; METASTASIS; MONOCYTE; MONONUCLEAR CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD PRESERVATION; BONE MARROW; BONE MARROW DISEASES; COMBINED MODALITY THERAPY; CRYOPRESERVATION; CYTOTOXICITY, IMMUNOLOGIC; DACARBAZINE; DOXORUBICIN; FEMALE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; IFOSFAMIDE; INTERFERON TYPE II; INTERLEUKIN-2; LEUKAPHERESIS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; NEOPLASMS; RECOMBINANT PROTEINS; TETANUS TOXOID; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0029759473     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy of malignancies. Blood 1991; 77: 211-213.
2. Juttner CA, To LA, Ho JQK et al. Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplant Proc 1988; 20: 40-42.
3. Henon PR, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992; 9: 285-291.
4. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogenic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
5. Ashihara E, Shimazake C, Yamagata N et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. Bone Marrow Transplant 1994; 13: 377-381.
6. Haas R, Ho AD, Bredthauer U et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 1990; 18: 94-98.
7. Korbling M, Holle R, Haas R et al. Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. J Clin Oncol 1990; 8: 978-985.
8. Bensinger W, Singer J, Applebaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 11: 3158-3163.
9. Bishop MR, Anderson JR, Jackson JD et al. High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 1994; 83: 610-616.
10. Wing EJ, Magee DM, Whiteside TL et al. Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients. Blood 1989; 73: 643-646.
11. Chachoua A, Oratz R, Hoogmoed R et al. Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factor. J Immunother 1994; 15: 217-224.
12. Morrissey PJ, Bressler L, Park LS et al. Granulocyte-macrophage colony stimulating factor augments the primary antibody response by enhancing the function of antigen presenting cells. J Immunol 1987; 139: 1113-1119.
13. Andreesen R, Scheibenbogen C, Brugger W et al. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res 1990; 50: 7450-7456.
14. Faradji A, Bohbot A, Schmitt-Goguel M et al. Phase I trial of intravenous infusion of ex vivo-activated autologous blood-derived macrophages in patients with non-small cell lung cancer: toxicity and immunomodulatory effects. Cancer Immunol Immunother 1991; 33: 319-326.
15. Kushner BH, Cheung NK. GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 1989; 73: 1936-1941.
16. Charak BS, Agah R, Mazumder A. Granulocyte-macrophage colony-stimulating factor-induced antibody-dependent cellular cytotoxicity in bone marrow macrophages: application in bone marrow transplantation. Blood 1993; 81: 3474-3479.
17. Weisenthal LM, Dill PL, Pearson FC. Effect of prior cancer chemotherapy on human tumor-specific cytotoxicity in vitro in response to immunopotentiating biologic response modifiers. J Natl Cancer Inst 1991; 83: 37-42.
18. Neubauer MA, Benyunes MC, Thompson JA et al. Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1994; 13: 311-316.
19. Verma UN, Areman E, Dickerson SA et al. Interleukin-2 activation of chemotherapy and growth factor-mobilized peripheral blood stem cells for generation of cytotoxic effectors. Bone Marrow Transplant 1995; 15: 199-206.
20. Taguchi K, Shibuya A, Inazawa Y, Abe T. Suppressive effect of granulocyte-macrophage colony stimulating factor on the generation of natural killer cells in vitro. Blood 1992; 79: 3227-3232.